Autologous dendritic cells transduced with Ad encoding NS3 (Clinica Universidad de Navarra)

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NameAutologous dendritic cells transduced with Ad encoding NS3 (Clinica Universidad de Navarra)

Drug Alias Name自体树突细胞

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHepatitis C, Chronic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesClinica Universidad De Navarra

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUniversity Of Navarra Clinica Universidad De Navarra

Active IndicationsN/A

Inactive IndicationsHepatitis C, Chronic

Other Information

ATC CodeN/A